Kindred Healthcare Gets a Hold Rating from RBC Capital

By Jason Carr

RBC Capital analyst Frank Morgan reiterated a Hold rating on Kindred Healthcare (NYSE: KND) yesterday and set a price target of $10. The company’s shares closed yesterday at $10.60.

According to TipRanks.com, Morgan is a top 100 analyst with an average return of 14.1% and a 67.4% success rate. Morgan covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care Corp, Quest Diagnostics Inc, and Surgery Partners Inc.

Kindred Healthcare has an analyst consensus of Hold, with a price target consensus of $10.

Based on Kindred Healthcare’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $1.77 billion and GAAP net loss of $5.75 million. In comparison, last year the company earned revenue of $1.84 billion and had a net profit of $12.55 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Kindred Healthcare, Inc. is a healthcare services company. The company, through its subsidiaries operates home health, hospice, and community care business; long-term acute care hospitals; inpatient rehabilitation hospitals; contract rehabilitation services business; non-medical home care sites; nursing centers; and assisted living facilities. Kindred Healthcare operates its business through the following divisions: Kindred at Home, Hospital, Kindred Rehabilitation Services, and Nursing Center. The company was founded on March 27, 1998, and is headquartered in Louisville, KY.